日本2型糖尿病患者季节性BMI波动幅度与肾功能下降风险(JDDM 82)
该研究基于日本全国多中心2014-2020年队列,纳入6700例2型糖尿病门诊患者,用季节趋势分解法量化年内BMI峰谷差。中位随访6.8年,779例达到主要终点;BMI波动每增加1个标准差,eGFR下降≥40%风险升高23%(HR 1.23,95%CI 1.16-1.31),最高三分位组风险为最低组的1.72倍(95%CI 1.42-2.09)。
要点
- 年内BMI波动越大,eGFR下降≥40%风险呈剂量依赖性升高。
- 最高三分位组eGFR下降≥40%风险为最低组的1.72倍。
- 季节性BMI波动或可识别肾功能下降高危的2型糖尿病患者。
核心结论
- 在2型糖尿病中,较大的年内BMI波动与肾功能下降独立且呈剂量依赖性相关。
- 季节性BMI波动幅度可能用于识别肾功能下降更高风险的个体。
- 减少季节性BMI波动能否改善肾脏结局尚需前瞻性评估。
研究设计与样本
- 日本全国多中心队列研究(2014-2020年),纳入6700例2型糖尿病门诊患者,中位随访6.8年。
- 采用季节趋势局部估计散点平滑法建模月度BMI,量化每例患者年内峰谷差。
- 以诊所为随机效应,使用多因素Cox模型估计关联。
主要发现
- 779例达到主要终点(eGFR下降≥40%)。
- BMI波动每增加1个标准差,eGFR下降≥40%风险升高(HR 1.23,95%CI 1.16-1.31)。
- 最高三分位组对比最低三分位组,eGFR下降≥40%风险为1.72倍(HR 1.72,95%CI 1.42-2.09)。
- eGFR下降≥30%(HR 1.18,95%CI 1.13-1.23)、肌酐翻倍(HR 1.30,95%CI 1.17-1.45)、新发CKD≥3期(HR 1.11,95%CI 1.07-1.16)结果一致。
- 纵向分析显示最高波动组eGFR下降更陡,敏感性分析(含时变用药暴露模型)结果稳健。
临床怎么用
- 对2型糖尿病患者可关注年内BMI峰谷差,作为肾功能下降的潜在风险标记。
- BMI波动幅度较大的患者或需更密切监测eGFR变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Body weight variability is linked to cardiometabolic outcomes, but its renal impact in type 2 diabetes remains uncertain. We tested whether the magnitude of seasonal BMI fluctuation is independently associated with kidney function decline. RESEARCH DESIGN AND METHODS: We analyzed a nationwide, multicenter Japanese cohort (2014-2020). Monthly BMI was modeled using seasonal-trend locally estimated scatterplot smoothing to quantify each participant's within-year peak-to-trough difference. The primary outcome was ≥40% decline in estimated glomerular filtration rate (eGFR). Secondary outcomes were ≥30% eGFR decline, creatinine doubling, incident chronic kidney disease (CKD) stage ≥3, and kidney failure. Associations were estimated using multivariable Cox models with clinic as a random effect. RESULTS: Among 6,700 outpatients (median follow-up: 6.8 years), 779 reached the primary end point. Each 1-SD increase in BMI fluctuation was associated with higher risk of ≥40% eGFR decline (hazard ratio [HR] 1.23, 95% CI 1.16-1.31). The highest versus lowest tertile showed a 1.7-fold increased risk (HR 1.72, 95% CI 1.42-2.09). Patterns were consistent for ≥30% eGFR decline (HR 1.18, 95% CI 1.13-1.23), creatinine doubling (HR 1.30, 95% CI 1.17-1.45), and incident CKD stage ≥3 (HR 1.11, 95% CI 1.07-1.16). Longitudinal analyses showed steeper eGFR decline in the highest-fluctuation group. Results were robust across sensitivity analyses, including models for time-varying medication exposure. CONCLUSIONS: In type 2 diabetes, larger intra-annual BMI fluctuations were independently and dose-dependently associated with kidney function decline. Seasonal BMI amplitude may identify higher-risk individuals; whether reducing seasonal BMI fluctuations improves kidney outcomes warrants prospective evaluation.
引用
- Toki R, Sakamoto M, Yuki M, et al. Seasonal BMI Amplitude and Risk of Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82). Diabetes Care. 2026. PMID: 41980087. doi:10.2337/dc26-0082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。